Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults

Annals of Allergy, Asthma and Immunology

Volumn 80, Issue 4, 1998, Pages 357-362

  Sydnor, T Austin ^a   Kopp, Elliot J ^b   Anthony, Kent E ^c   LoCoco, John M ^d   Kim, Sun Sook ^d   Fowler, Cynthia L ^d  

^a Virginia Medical Studies Group   (United States)

^b Carolina Arthr Allerg R   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MORAXELLA CATARRHALIS; PARANASAL SINUSITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA;

EID: 0031945630     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62983-3     Document Type: Article

References (13)

1. Williams JW Jr, Simel DL. Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination. JAMA 1993;270: 1242-6.
2. Diaz I, Bamberger DM. Acute sinusitis. Semin Respir Infect 1995; 10: 14-20.
3. Ferguson BJ. Acute and chronic sinusitis. How to ease symptoms and locate the cause. Postgrad Med 1995;97: 45-8,51-2,55-7.
4. Gwaltney JM Jr, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992;90(3 Pt 2): 457-62.
5. Fu KP, Lafredo SC, Foleno B, et al. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob Agents Chemother 1992;36:860-6.
6. Davis R, Bryson HM. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 1994;47:677-700.
7. Klugman KP, Capper T, Bryskier A. In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin. Antimicrob Agents Chemother 1996;40:2802-4.
8. Beidenbach DJ, Jones RN. The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci. Diagn Microbiol Infect Dis 1996;25:47-51.
9. Eliopoulos GM, Wennersten CB, Moellering RC Jr. Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria. Diagn Microbiol Infect Dis 1996; 25:35-41.
10. Plouffe JF. Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1996;25:43-5.
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-Third Edition; Approved Standard. M7-A3. Villanova, Pa; 1993:Vol 13, No. 25.
12. Adelglass J, DeAbate CA, McElvaine P, Fowler CL. A comparison of levofloxacin and amoxicillin/clavulanate for the treatment of acute bacterial sinusitis in adults. Clin Infect Dis 1996; 23:913.
13. Cormican MG, Erwin ME, Marshall SA, Jones RN. Susceptibility testing interpretive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalis. Diagn Microbiol Infect Dis 1996;24:155-60.